• News
  • Defense

Marine Corps Trials heading to Camp Pendleton

The fourth annual Marine Corps Trials, hosted by the Marine Corps Wounded Warrior Regiment, will take place at Camp Pendleton from March 4 through 12.

The Marine Corps Trials is an eight-sport Paralympic-style invitational involving more than 300 wounded, ill or injured Marines and international competitors. Participants will be organized into four competing teams: two active duty teams, a Marine veteran team, and an international team comprised of wounded warriors from our international allies.

Participants will compete in two or three of the eight events: archery, shooting, swimming, track, field, cycling, sitting volleyball, and wheelchair basketball. More than 50 world class coaches will be on hand to train and coach the participants beginning March 4, with competitions commencing the on March. 7.

The purpose of the Marine Corps Trials is to provide an opportunity for all wounded, ill or injured Marines to further the rehabilitation of their minds, bodies, and spirits through competition and camaraderie. For some, the Trials are a milestone in their personal athletic goals. For others, it is an opportunity to experience new activities and connect with their fellow wounded warriors. For all of the participants, the Trials are a chance to come together and focus on their abilities, not their disabilities.

Participation is open to active duty, reserve, and veteran wounded, ill, or injured Marines of all skill levels. The international team will be comprised of wounded warriors from Australia, Canada, Colombia, France, Georgia, Germany, the Netherlands, New Zealand, and the United Kingdom.

Spectators are welcome, with parking and admission free to the public. Non-military spectators need to bring a valid driver’s license and registration, and all visitors must enter Camp Pendleton using the far right visitor lanes at each gate. The final schedule will be posted at www.woundedwarriorregiment.org and http://Facebook.com/wwr.usmc on March 1.

User Response
0 UserComments